Literature DB >> 14740969

How to use statins in patients with chronic liver disease.

Mark W Russo1, Ira M Jacobson.   

Abstract

Clinicians may be concerned about prescribing statins to patients with chronic liver disease, but there is little evidence to suggest that drug-induced liver injury from statins is increased in these patients. Thus, we should prescribe statins for the same indications in patients with chronic liver disease as in patients without, but with closer monitoring. However, patients with acute liver disease (acute viral hepatitis, alcoholic hepatitis) should not take statins until they have recovered.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14740969     DOI: 10.3949/ccjm.71.1.58

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN: 0891-1150            Impact factor:   2.321


  7 in total

Review 1.  Statins in the treatment of dyslipidemia in the presence of elevated liver aminotransferase levels: a therapeutic dilemma.

Authors:  Rossana M Calderon; Luigi X Cubeddu; Ronald B Goldberg; Eugene R Schiff
Journal:  Mayo Clin Proc       Date:  2010-04       Impact factor: 7.616

2.  Rhabdomyolysis after midazolam administration in a cirrhotic patient treated with atorvastatin.

Authors:  Antonietta Gigante; Gianluca Di Lazzaro Giraldi; Maria Ludovica Gasperini; Biagio Barbano; Marta Liberatori; Liborio Sardo; Francesca Di Mario; Antonella Giorgi; Filippo Rossi-Fanelli; Antonio Amoroso
Journal:  World J Gastrointest Pharmacol Ther       Date:  2014-08-06

Review 3.  Drug-induced liver injury: is it somehow foreseeable?

Authors:  Giovanni Tarantino; Matteo Nicola Dario Di Minno; Domenico Capone
Journal:  World J Gastroenterol       Date:  2009-06-21       Impact factor: 5.742

4.  Statin use in patients with cirrhosis: a retrospective cohort study.

Authors:  Sonal Kumar; Norman D Grace; Amir A Qamar
Journal:  Dig Dis Sci       Date:  2014-05-18       Impact factor: 3.199

5.  Fatal rhabdomyolysis in a patient with liver cirrhosis after switching from simvastatin to fluvastatin.

Authors:  Seung Don Baek; Sun-Joo Jang; So-Eun Park; Tae Jin Ok; Jaechan Leem; Ho-Su Lee; So Jung Park; Tae Hee Kim
Journal:  J Korean Med Sci       Date:  2011-11-29       Impact factor: 2.153

6.  Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert Panel.

Authors:  Maciej Banach; Manfredi Rizzo; Peter P Toth; Michel Farnier; Michael H Davidson; Khalid Al-Rasadi; Wilbert S Aronow; Vasilis Athyros; Dragan M Djuric; Marat V Ezhov; Robert S Greenfield; G Kees Hovingh; Karam Kostner; Corina Serban; Daniel Lighezan; Zlatko Fras; Patrick M Moriarty; Paul Muntner; Assen Goudev; Richard Ceska; Stephen J Nicholls; Marlena Broncel; Dragana Nikolic; Daniel Pella; Raman Puri; Jacek Rysz; Nathan D Wong; Laszlo Bajnok; Steven R Jones; Kausik K Ray; Dimitri P Mikhailidis
Journal:  Arch Med Sci       Date:  2015-03-14       Impact factor: 3.318

7.  Physicochemical Properties and Effects of Fruit Pulps from the Amazon Biome on Physiological Parameters in Rats.

Authors:  Fernanda Rosan Fortunato Seixas; Bruna Kempfer Bassoli; Lara Borghi Virgolin; Laís Chancare Garcia; Natália Soares Janzantti
Journal:  Nutrients       Date:  2021-04-28       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.